Trials / Unknown
UnknownNCT02842294
Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer
Etude de Cohorte évaluant l'Impact de l'Association chimiothérapie et Bevacizumab en 1ère Ligne du Cancer Colorectal métastatique Sur la qualité de Vie Relative Des Patients. Etude COBEQOL
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this french multicenter national study is to assess and compare time to quality of life score deterioration (targeted dimensions : global health, fatigue and emotional functionning of EORTC QLQC30 according to the first line chemotherapy associated with bevacizumab in metastatic colorectal patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2017-02-01
- Completion
- 2018-02-01
- First posted
- 2016-07-22
- Last updated
- 2016-07-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02842294. Inclusion in this directory is not an endorsement.